
Table of Contents
The profit margin in a PCD Pharma franchise business generally ranges between 20% to 60%, depending on the product category, monopoly rights, company support, and market demand. Premium products such as antibiotics, nutraceuticals, derma, cardiac, and ayurvedic ranges often provide higher margins.
| Product Segment | Approx. Profit Margin |
|---|---|
| Tablets & Capsules | 20% – 35% |
| Syrups & Suspensions | 25% – 40% |
| Nutraceutical Products | 30% – 50% |
| Ayurvedic Medicines | 40% – 60% |
| Derma & Cosmetic Range | 35% – 55% |
| Injectables | 20% – 30% |
Dexon Biotech Pvt. Ltd. is a professionally managed and rapidly growing pharmaceutical company based in Ambala Cantt, Haryana, India. The company specializes in PCD Pharma Franchise services and offers a wide range of high-quality pharmaceutical products across India. Established in 2016, the company has built a strong reputation for quality, customer satisfaction, and ethical business practices.
Dexon Biotech focuses on delivering affordable and effective medicines while maintaining strict quality control standards. With a strong distribution network and customer-focused approach, the company offers monopoly-based PCD Pharma Franchise opportunities across India.
A well-managed PCD Pharma franchise can become a highly profitable business with comparatively low investment and strong long-term growth potential.
To provide high-quality pharmaceutical products with complete customer satisfaction while continuously expanding healthcare reach across India.
To become a trusted transnational pharmaceutical company through innovation, quality products, and long-term business partnerships.